2021

16 April 2021

Law School academics recognised in Best Lawyers Australia 2022

Best Lawyers is a respected peer review publication, highlighting the extraordinary accomplishments of the legal profession. Recognition in the publication is regarded as a significant honour.

16 April 2021

Where can a Juris Doctor degree lead you?

The Juris Doctor in Australia is a highly regarded graduate entry degree. At the University of Sydney School of Law we prepare professional lawyers with strong analysis, research, writing and advocacy skills.

15 April 2021

Addressing the politics of knowledge production

The politics of knowledge production is central to the way academics at Australian universities who work in Southeast Asia manage their relationships in the region. How can we address power imbalances between the Global North and the Global South?

15 April 2021

MBI announced as Flagship Centre

As part of their 2025 Strategy, the Faculty of Medicine and Health embarked on a review of its Research Centres to determine where they should strategically focus their research support and investment.

15 April 2021

MBI announced as Flagship Centre

As part of their 2025 Strategy, the Faculty of Medicine and Health embarked on a review of its Research Centres to determine where they should strategically focus their research support and investment.

15 April 2021

Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living With Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies

Cryptococcal meningitis (CM), a life-threatening systemic, opportunistic fungal infection, occurs mainly in patients with defective cellular immunity. Cryptococcal antigen (CrAg) detection could direct the timely initiation of antifungal therapy.

15 April 2021

Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living With Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies

Cryptococcal meningitis (CM), a life-threatening systemic, opportunistic fungal infection, occurs mainly in patients with defective cellular immunity. Cryptococcal antigen (CrAg) detection could direct the timely initiation of antifungal therapy.

15 April 2021

Not if but when - Sydney can expect more flood disasters

Sydney's recent disastrous flood wasn't unprecedented but we can expect more major events within 10 years, says Associate Professor Thomas Hubble from the School of Geosciences.

15 April 2021

Dorothy Hoddinott awarded honorary doctorate

The University of Sydney has awarded an honorary doctorate to Dorothy Hoddinott AO in recognition of her outstanding contributions to public education, social justice and human rights.

14 April 2021

New Director for the Henry Halloran Trust

Professor Peter Phibbs, after leading the Henry Halloran Trust since 2013, has stepped down from his role and has been succeeded by Professor Nicole Gurran, from the Sydney School of Architecture, Design and Planning.

14 April 2021

Active case‐finding in contacts of people with TB

Exposure to people with TB substantially elevates a person’s risk of tuberculous infection and TB disease. Systematic screening of TB contacts enables the early detection and treatment of co-prevalent disease, and the opportunity to prevent future TB disease.

14 April 2021

Active case‐finding in contacts of people with TB

Exposure to people with TB substantially elevates a person’s risk of tuberculous infection and TB disease. Systematic screening of TB contacts enables the early detection and treatment of co-prevalent disease, and the opportunity to prevent future TB disease.

14 April 2021

Determining the value of TB active case-finding: current evidence and methodological considerations

Active case-finding (ACF) is an important component of the End TB Strategy. However, ACF is resource-intensive, and the economics of ACF are not well-understood. Research is essential to the optimal implementation, cost-effectiveness, and affordability of ACF in high-burden settings.

14 April 2021

Determining the value of TB active case-finding: current evidence and methodological considerations

Active case-finding (ACF) is an important component of the End TB Strategy. However, ACF is resource-intensive, and the economics of ACF are not well-understood. Research is essential to the optimal implementation, cost-effectiveness, and affordability of ACF in high-burden settings.

14 April 2021

Epidemiology of Healthcare-Associated Infections in Australia

This is Australia’s first peer-reviewed evidence-based assessment of the epidemiology of HAIs using publicly available data from hospital-acquired complications (HACs) state-based surveillance systems and peer-reviewed and grey literature sources.

14 April 2021

Epidemiology of Healthcare-Associated Infections in Australia

This is Australia’s first peer-reviewed evidence-based assessment of the epidemiology of HAIs using publicly available data from hospital-acquired complications (HACs) state-based surveillance systems and peer-reviewed and grey literature sources.

14 April 2021

The Model Crisis, or how to have critical promiscuity in the time of Covid-19

During the past forty years, statistical modelling and simulation have come to frame perceptions of epidemic disease and to determine public health interventions that might limit or suppress the transmission of the causative agent. The influence of such formulaic disease modelling has pervaded public health policy and practice during the Covid-19 pandemic.

14 April 2021

The Model Crisis, or how to have critical promiscuity in the time of Covid-19

During the past forty years, statistical modelling and simulation have come to frame perceptions of epidemic disease and to determine public health interventions that might limit or suppress the transmission of the causative agent. The influence of such formulaic disease modelling has pervaded public health policy and practice during the Covid-19 pandemic.

14 April 2021

What is Novavax, Australia's third COVID vaccine option?

Australia has a deal for a third vaccine developed by US biotech company Novavax. Professor Jamie Triccas explains more about this 'protein subunit' vaccine, which is yet to be approved by the Therapeutic Goods Administration.

14 April 2021

Pritzker Architecture Prize Laureates lead symposium

Sydney School of Architecture, Design and Planning (SADP) will host the inaugural Rothwell Chair Symposium this April. Curated by SADP and Rothwell Co-Chairs, the 2021 Pritzker Prize Laureates, Lacaton & Vassal, the symposium will focus on international and local social and affordable housing design.